| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75907SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81039-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11997-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47947-0.1mg | |||
![Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-hu5c8-Ruplizumab-Western-Blot-NBP2-75907-img0001.jpg "Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.")
![Western Blot: TRPM7 Antibody [NBP3-23361] - Western blot image of rat PC12 cells (lanes 1-4). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 (lanes 2 & 4). The blot was probed with rabbit polyclonals anti-TRPM7 (Extracellular region) NBP3-23361 (lanes 1 & 2) or anti-TRPM7 (Ser-1569) phospho-specific (lanes 3 & 4).](http://images.novusbio.com/fullsize/nbp3-23361_rabbit-trpm7-pab-119202316331624.jpg "Western Blot: TRPM7 Antibody [NBP3-23361] - Western blot image of rat PC12 cells (lanes 1-4). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 (lanes 2 & 4). The blot was probed with rabbit polyclonals anti-TRPM7 (Extracellular region) NBP3-23361 (lanes 1 & 2) or anti-TRPM7 (Ser-1569) phospho-specific (lanes 3 & 4).")
![Western Blot: eNOS [p Ser632] Antibody (M232) [NBP3-23181] - Western blot analysis of human umbilical vein endothelial cells stimulated with Calyculin A and untreated (lanes 1, 3, 5) or treated (lanes 2, 4, 6) with lambda phosphatase. The blots were probed with anti-endothelial Nitric Oxide Synthase (eNOS) monoclonal antibody (lanes 1 & 2), anti-eNOS (Ser-632) phospho-specific antibody (lanes 3 & 4), and anti-eNOS polyclonal antibody (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23181_mouse-enos-p-ser632-mab-m232-11920231665313.jpg "Western Blot: eNOS [p Ser632] Antibody (M232) [NBP3-23181] - Western blot analysis of human umbilical vein endothelial cells stimulated with Calyculin A and untreated (lanes 1, 3, 5) or treated (lanes 2, 4, 6) with lambda phosphatase. The blots were probed with anti-endothelial Nitric Oxide Synthase (eNOS) monoclonal antibody (lanes 1 & 2), anti-eNOS (Ser-632) phospho-specific antibody (lanes 3 & 4), and anti-eNOS polyclonal antibody (lanes 5 & 6).")
![Western Blot: TRPM7 [p Ser1513] Antibody [NBP3-23186] - Western blot image of human autophosphorylated TRPM7 C-terminal kinase domain (lanes 1-6). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 phosphosites (lanes 2, 4, & 6). The blot was probed with rabbit polyclonals anti-TRPM7 (Ser-1513) phospho-specific (lanes 1 & 2), anti-TRPM7 (a.a.1484-1497) NBP3-23362 antibody (lanes 3 & 4), or anti-TRPM7 (Ser-1493) phospho-specific (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23186_rabbit-trpm7-p-ser1513-pab-199202312523634.jpg "Western Blot: TRPM7 [p Ser1513] Antibody [NBP3-23186] - Western blot image of human autophosphorylated TRPM7 C-terminal kinase domain (lanes 1-6). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 phosphosites (lanes 2, 4, & 6). The blot was probed with rabbit polyclonals anti-TRPM7 (Ser-1513) phospho-specific (lanes 1 & 2), anti-TRPM7 (a.a.1484-1497) NBP3-23362 antibody (lanes 3 & 4), or anti-TRPM7 (Ser-1493) phospho-specific (lanes 5 & 6).")
![Western Blot: TRPM7 [p Ser1569] Antibody [NBP3-23192] - Western blot image of rat PC12 cells (lanes 1-4). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 (lanes 2 & 4). The blot was probed with rabbit polyclonals anti-TRPM7 (Extracellular region) NBP3-23361 (lanes 1 & 2) or anti-TRPM7 (Ser-1569), phospho-specific (lanes 3 & 4).](http://images.novusbio.com/fullsize/nbp3-23192_rabbit-trpm7-p-ser1569-pab-19920231856911.jpg "Western Blot: TRPM7 [p Ser1569] Antibody [NBP3-23192] - Western blot image of rat PC12 cells (lanes 1-4). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 (lanes 2 & 4). The blot was probed with rabbit polyclonals anti-TRPM7 (Extracellular region) NBP3-23361 (lanes 1 & 2) or anti-TRPM7 (Ser-1569), phospho-specific (lanes 3 & 4).")
![Western Blot: eNOS Antibody [NBP3-23180] - Western blot analysis of human umbilical vein endothelial cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3, 5 & 7) then the blots were treated with lambda phosphatase (lanes 2, 4, 6 & 8). The blots were probed with anti-endothelial nitric oxide synthase (eNOS) (C-terminal region) (lanes 1 & 2), anti-eNOS (Ser-632) (lanes 3 & 4), anti-eNOS (Ser-1177) (lanes 5 & 6) and anti-eNOS (a.a. 1172-1181) (lanes 7 & 8).](http://images.novusbio.com/fullsize/nbp3-23180_rabbit-enos-pab-19920231759442.jpg "Western Blot: eNOS Antibody [NBP3-23180] - Western blot analysis of human umbilical vein endothelial cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3, 5 & 7) then the blots were treated with lambda phosphatase (lanes 2, 4, 6 & 8). The blots were probed with anti-endothelial nitric oxide synthase (eNOS) (C-terminal region) (lanes 1 & 2), anti-eNOS (Ser-632) (lanes 3 & 4), anti-eNOS (Ser-1177) (lanes 5 & 6) and anti-eNOS (a.a. 1172-1181) (lanes 7 & 8).")
![Western Blot: TRPM7 Antibody (M573) [NBP3-23439] - Western blot image of TRPM7 expression in human MCF-7 cell lysate. The blot was probed with mouse monoclonal anti-TRPM7 (Extracellular region) M573 at a dilution of 1:250.](http://images.novusbio.com/fullsize/nbp3-23439_mouse-trpm7-mab-m573-11920231633167.jpg "Western Blot: TRPM7 Antibody (M573) [NBP3-23439] - Western blot image of TRPM7 expression in human MCF-7 cell lysate. The blot was probed with mouse monoclonal anti-TRPM7 (Extracellular region) M573 at a dilution of 1:250.")
![Flow Cytometry: Insulin R/CD220 Antibody (83-7) [NBP2-81039] - Flow-cytometry using the Insulin R/CD220 Antibody (83-7) [NBP2-81039]. Jurkat cells were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of 83-7 (NBP2-81039, blue line) at a concentration of 10 ug/ml for 30 mins at RT. After washing, bound antibody was detected using anti-rabbit IgG JK (FITC-conjugate) antibody at 2 ug/ml and cells analyzed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Insulin-R-CD220-Antibody-83-7-Flow-Cytometry-NBP2-81039-img0001.jpg "Flow Cytometry: Insulin R/CD220 Antibody (83-7) [NBP2-81039] - Flow-cytometry using the Insulin R/CD220 Antibody (83-7) [NBP2-81039]. Jurkat cells were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of 83-7 (NBP2-81039, blue line) at a concentration of 10 ug/ml for 30 mins at RT. After washing, bound antibody was detected using anti-rabbit IgG JK (FITC-conjugate) antibody at 2 ug/ml and cells analyzed on a FACSCanto flow-cytometer.")
![Western Blot: ER alpha/NR3A1 Antibody (ER505) - Azide and BSA Free [NBP2-33106] - Western blot analysis of Estrogen Receptor in MCF-7 lysate using Estrogen Receptor Ab (ER505).](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER505-Azide-and-BSA-Free-Western-Blot-NBP2-33106-img0003.jpg "Western Blot: ER alpha/NR3A1 Antibody (ER505) - Azide and BSA Free [NBP2-33106] - Western blot analysis of Estrogen Receptor in MCF-7 lysate using Estrogen Receptor Ab (ER505).")
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (Ks19.1) - IHC-Prediluted [NBP2-48096] - Human Ovarian Carcinoma stained with Cytokeratin 19 Ab (Ks19.1).](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-Ks19-1-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48096-img0003.jpg "Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (Ks19.1) - IHC-Prediluted [NBP2-48096] - Human Ovarian Carcinoma stained with Cytokeratin 19 Ab (Ks19.1).")
![Immunohistochemistry-Paraffin: TSH R Antibody (TSHRB/1405) [NBP2-54322] - Formalin-fixed, paraffin-embedded human Thyroid Carcinoma stained with TSHRB Monoclonal Antibody (TSHRB/1405).](http://images.novusbio.com/fullsize/TSH-R-Antibody-TSHRB-1405-Immunohistochemistry-Paraffin-NBP2-54322-img0001.jpg "Immunohistochemistry-Paraffin: TSH R Antibody (TSHRB/1405) [NBP2-54322] - Formalin-fixed, paraffin-embedded human Thyroid Carcinoma stained with TSHRB Monoclonal Antibody (TSHRB/1405).")